Mucinous precursor lesions of mucinous carcinoma in breast: Incidence and histopathologic features

Min Jung Jung; Young Ok Kim

doi:10.7180/kmj.2015.30.2.131

Journal List > Kosin Med J > v.30(2) > 1057045

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jung and Kim: Mucinous precursor lesions of mucinous carcinoma in breast: Incidence and histopathologic features

Original Article

Kosin Medical Journal 2015;30(2):131-139.

Published online: 20 January 2015

DOI: https://doi.org/10.7180/kmj.2015.30.2.131

Mucinous precursor lesions of mucinous carcinoma in breast: Incidence and histopathologic features

Min Jung Jung, Young Ok Kim

Department of Pathology, College of Medicine, Kosin University, Busan, Korea

Corresponding Author: Young Ok Kim, Department of Pathology, College of Medicine, Kosin University, 262, Gamcheon-ro, Seo-gu, Busan 49267, Korea Tel: 82-51-990-6325 Fax: 82-51-990-3080 E-mail: suajoon@ns.kosinmed.or.kr

Received 1 October 201418 December 2014 Accepted 4 January 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objectives

Columnar cell lesion (CCL), atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS) may be premalignant lesion of mammary invasive carcinoma. A few recent investigators reported that the precursor lesions exhibited mucin production and they might be potential precursor lesion for mucinous carcinoma (mCA). This study aims to investigate the incidence and histopathologic characteristics of mucinous precursor lesions, including mucinous DCIS (mDCIS) and mucinous CCL (mCCL).

Methods

We retrospectively analyzed invasive carcinomas with mucin. Cases were grouped into three subgroups: pure mCA, mixed mCA, and invasive carcinoma of no special type with mucin production (IC of NST-m). Precursor lesions were evaluated with PAS and alcian blue staining.

Results

Total 27 cases of invasive carcinoma with mucin were analysed and classified as 18 pure mCA, 7 mixed mCA, and 2 IC of NST-m. mDCISs were found in 12 pure mCA, 4 mixed mCA and 2 IC of NST-m. mCCLs were found in 7 pure mCA and 2 mixed mCA. Majority of mucin was identified in both cytoplasm and ductal lumen, while some tumors exhibited only cytoplasmic mucin. We also observed three patterns of mDCIS classifiable by location of mucin and architecture of tumor cells.

Conclusions

Cytoplasmic mucin suggested that mucinous feature of precursor lesions in the vicinity of mCA might not be a passive morphologic finding but be involved in development of mCA.

Keywords: Breast, Mucin, Mucinous carcinoma, Precursor

References

1. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 2008; 32:513–23.

2. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005; 29:734–46.

3. Sunil R. Lakhani IOE, Stuart J Schinitt, Puay Hoon Tan, Marc J. van de Vijver. WHO classification of tumours of the breast. 4th Edition ed. Fred T. Bosman ESJ, Sunil R. Lakhani, Hiroko Ohgaki, editor. Geneva: International Agency for Research on Cancer;2012.

4. Go EM, Tsang JY, Ni YB, Yu AM, Mendoza P, Chan SK, et al. Relationship between columnar cell changes and low-grade carcinoma in situ of the breast–a cytogenetic study. Hum Pathol. 2012; 43:1924–31.

5. Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Cancer. 2000; 88:2072–81.

6. Schnitt SJ. The diagnosis and management of preinvasive breast disease: flat epithelial atypia–classification, pathologic features and clinical significance. Breast Cancer Res. 2003; 5:263–8.

7. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007; 31:417–26.

9. Gadre SA, Perkins GH, Sahin AA, Sneige N, Deavers MT, Middleton LP. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion. Histopathology. 2008; 53:545–53.

10. Kryvenko ON, Chitale DA, Yoon J, Arias-Stella J 3rd, Meier FA, Lee MW. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases. Am J Surg Pathol. 2013; 37:1076–84.

11. O'Connell JT, Shao ZM, Drori E, Basbaum CB, Barsky SH. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol. 1998; 29:1517–23.

12. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat. 2008; 111:541–7.

13. Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology. 2003; 42:26–36.

14. Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer. 1988; 61:989–96.

Figure 1.

Distribution of ductal carcinoma in situ, mucinous ductal carcinoma in situ, columnar cell lesion and mucinous columnar cell lesion is variable in each groups of invasive carcinoma with mucin. (DCIS, ductal carcinoma in situ; mDCIS, mucinous ductal carcinoma in situ; CCL, columnar cell lesion; mCCL, mucinous columnar cell lesion; mCA, mucinous carcinoma; IC of NST-m, invasive carcinoma of no special type with mucin production)

Figure 2.

Mucinous ductal carcinoma in situ is histologically classified into three patterns. (A) In pattern 1, ductal carcinoma in situ exhibits ducts overextended by intraluminal mucin. (B) They are partially lined by attenuated ductal epithelium. (C, D) In pattern 2, ductal carcinoma in situ exhibits intraluminal mucin without ductal overextension. (E, F) In pattern 3, ductal carcinoma in situ exhibits minute intercellular spaces or intracytoplasmic vacuoles filled with mucin without distinct ductal mucin. (Hematoxylin-Eosin stain, A, C, E: x40, B, D, F: x400)

Figure 3.

Three patterns of mucinous ductal carcinoma in situ are identified in three groups of invasive carcinoma with mucin. Some cases exhibit more than one pattern of mucinous ductal carcinoma in situ, and most common pattern is pattern 3. (DCIS, ductal carcinoma in situ, mCA, mucinous carcinoma; IC of NST-m, invasive carcinoma of no special type with mucin production)

Table 1.

Clinicopathologic characteristics of invasive carcinoma with mucin

Characteristic/Group	Pure mCA (n=18)	Mixed mCA (n=7)	IC of NST-m (n=2)
Gender	Female (18)	Female (7)	Female (2)
Age (average)	49.9 years	57.7 years	45 years
(Min-Max)	(29–73)	(40–77)	(41–49)
Operation type	M (9) E (1) E+M (8)	M (5) E+M (2)	M (1) E+M (1)
Tumor size (average)	25.72mm	22.4mm	23.5mm
(Min-Max)	(3–58)	(10–50)	(22–25)
Lymph node metastasis	–	–	+ (1)
	– (16)
Non-mucinous component	IC with SRC diff (1)	IC of NST (7)	IC of NST (2)
	IC of NST (1)
Microcalcification	+ (13)	+ (5)	+ (2)

mCA, mucinous carcinoma; IC of NST-m, invasive carcinoma of no special type with mucin production; Min, minimal; Max, maximal; M, mastectomy; E, excision; E+M, excision with subsequent mastectomy; +, present; -, absent; IC with SRC diff, invasive carcinoma with signet-ring cell differentiation; IC of NST, invasive carcinoma of no special type

Table 2.

Histopathologic characteristics of mucinous precursor lesions

Group\Precursor	Case	DCIS	mDCIS (location / pattern)	CCL	mCCL (location)
	1	+	+ (L, C / pattern 1,2)	+	+ (L, C)
	2	+	–	–	NA
	3	+	+ (C/ pattern 3)	+	–
	4	+	–	+	+ (C)
	5	+	+ (L, C / pattern 1,2,3)	+	+ (L)
	6	+	+ (L, C / pattern 1,2,3)	–	NA
	7	+	+ (L, C / pattern 1,2,3)	–	NA
	8	–	NA	–	NA
Pure mCA (n=18)	9	+	+ (C / pattern 3)	+	+ (L, C)
	10	+	+ (L, C / pattern 1,2,3)	–	NA
	11	–	NA	–	NA
	12	–	NA	–	NA
	13	+	+ (L, C / pattern 1,3)	+	+ (L, C)
	14	–	NA	+	+ (L, C)
	15	+	+ (L, C / pattern 2,3)	+	+ (L, C)
	16	+	+ (L, C / pattern 2)	–	NA
	17	+	+ (L, C / pattern 3)	+	–
	18	+	+ (C / pattern 3)	–	NA
	19	+	+ (L, C / pattern 1,2,3)	–	NA
	20	+	–	+	+ (L, C)
Mixed mCA (n=7)	21	+	+ (C / pattern 3)	+	–
	22	+	–	–	NA
	23	+	+ (L, C / pattern 3)	+	+ (C)
	24	+	+ (L, C / pattern 1,2,3)	–	NA
	25	+	–	–	NA
IC of NST-m (n=2)	26	+	+ (L, C / pattern 2,3)	–	NA
	27	+	+ (L, C / pattern 3)	–	NA

mCA, mucinous carcinoma; IC of NST-m, invasive carcinoma of no special type with mucin production; DCIS, ductal carcinoma in situ; mDCIS, mucinous ductal carcinoma in situ; CCL, columnar cell lesion; mCCL, mucinous columnar cell lesion; +, present; -, absent; NA, not available; L, ductal lumen; C, cytoplasm

TOOLS

Similar articles